Ernexa Therapeutics Inc. Facility Costs
Ernexa Therapeutics Inc. (ERNA) reported Facility Costs of $45.00 thousand for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FacilityCosts · last filed 2018-08-06
- Ernexa Therapeutics Inc. facility costs for fiscal 2017 was $45.00K.
| Period end | Facility Costs 6 month | Facility Costs 12 month |
|---|---|---|
| 2018-06-30 | $45.00K 10-Q · filed 2018-08-06 | |
| 2017-12-31 | $45.00K 10-K · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |